Dr. John Cush RheumNow
8 months ago
Testing for RF, CCP, ESR and CRP
Check out the accompanying Advanced Practice Rheum: Rheumatoid and Inflammation Testing video.
https://t.co/o1sle6CKg5 https://t.co/roYXcbPdBh
Dr. John Cush RheumNow
8 months ago
Advanced Practice Rheum: Methotrexate
https://t.co/PHAFWBG4gJ https://t.co/p9cMqT4nhR
A 5 year JAMA study shows that a treat-to-target (serum urate < 6 mg/dL) study finds that effective urate-lowering treatment (ULT) results in a significantly reduced cardiovascular risk in patients with gout.
NatRevRheumatol NatRevRheumatol
8 months ago
New content online: Recommendations for the use of CLASI as an outcome measure in cutaneous lupus erythematosus clinical trials https://t.co/nDxfWWgutC https://t.co/Z6JMojdBz4
Ravi Kumar RheumattDoc
8 months ago
🧬 PAPA Syndrome: When Sterile Inflammation Mimics Infection
(Pyogenic Arthritis, Pyoderma gangrenosum, Acne)
•A rare monogenic autoinflammatory disease
•Caused by gain-of-function mutations in PSTPIP1
🧠 Pathophysiology
•Mutant PSTPIP1 → increased interaction with pyrin https://t.co/tJ4INdgfky
Dr. John Cush RheumNow
8 months ago
Rheum Poll> Which is the most difficult to treat RA (D2TRA) patient (despite aggressive Rx)?
Dr. John Cush RheumNow
8 months ago
BIOBADASER III Registry shows No Cancer Risk with b/tsDMARDs
A large, real-world cohort study of rheumatoid arthritis (RA) finds patients treated with biologic and targeted synthetic DMARDs (b/tsDMARDs) do not have an increased risk of cancer.
https://t.co/0oawv88Anq https://t.co/nrsok06gKV
Aurelie Najm AurelieRheumo
8 months ago
Kick off 2026 with #RheumNowLive—two days of cutting-edge rheumatology, rapid-fire STEP talks, interactive Q&A, and real-world insights with Drs. Jack Cush, Arthur Kavanaugh, and a powerhouse faculty. Register: https://t.co/zh0aBDMfoP
@RheumNow
Dr. John Cush RheumNow
8 months ago
APPIPRA Study - Benefits of Early Treatment
Treating people who are at high risk of rheumatoid arthritis (RA) can delay the onset of the disease for several years, with benefits also continuing well after treatment has stopped.
https://t.co/hgxj936CWn https://t.co/eJX3amp3Id
A recent study examines trends in rheumatoid arthritis (RA)-related mortality among U.S. postmenopausal women (aged 55 and older). They found RA mortality rates have declined, yet disparities in who is most affected persist, especially for white women, and those over 85 yrs of age.
Dr. John Cush RheumNow
8 months ago
Turkish study of 128 Psoriatics (62 PSO, 66 PsA) found more periodontitis in PsA vs PSO (47% vs 31%; P=.058). Signif. higher levels of Dz activity seen for PSO (CPDAI: OR 1.38; P = .001) & enthesitis (MASES: OR 1.39; P < .001) if periodontitis present in PsA patients. https://t.co/d8OfarFWeG
Dr. John Cush RheumNow
8 months ago
What Is Restless Legs Syndrome? JAMA Patient Education handout. https://t.co/fCqArVxrSu https://t.co/WjFNWyr9Q2
Dr. John Cush RheumNow
8 months 1 week ago
Evaluation of pts w/ muscle weakness and elevated muscle enzymes https://t.co/faTWMscUzz https://t.co/Dcx8m4Ny7Y
Dr. John Cush RheumNow
8 months 1 week ago
“We will remember not the words of our enemies, but the silence of our friends.”
- Martin Luther King, Jr.
Dr. John Cush RheumNow
8 months 1 week ago
Drugs that may cause toxic myopathy, presenting as muscle dysfunction w/ weakness and elevated muscle enzymes and possibly confused w/ idiopathic inflammatory myopathies (IIM) - full read review of mimickers of myositis. https://t.co/1Yn3OXXEH6 https://t.co/HmQiYFSQMU
